DRI was categorized at 40.
Thereby, baseline CEA serum levels (categorized at 26.8 ng/mL) were not associated with either DC (P = 0.281; Fig. 4a) or PFS (P = 0.221; Fig. 4b).
Multiple Cox survival analysis was used to assess the associations between carotid-femoral PWV, as a continuous variable and categorized at 10 m/s, and the end points.
Table 4 shows that there is a statistically significant difference between the 'recurrent pain' and the 'continuous pain' group (categorized at Q3) regarding SRH status during pregnancy (Q1) (p = 0.041) and during the first 6 months postpartum (Q2) (p = 0.050).
Table 2 shows the results of Cox proportional hazards regression for carotid-femoral PWV analyzed as a continuous variable and categorized at 10 m/s as a predictor of the two primary end points.
Over a period of 4 years, a total of 61 GRMD dogs were included in the study; they were all tested at 2 months of age, and categorized at 6 months of age upon their ambulation status: ambulant at 6 months of age (moderate form) versus non-ambulant at 6 months of age (severe form).
This study showed that there was a statistically significant difference in regard to SRH between the 'recurrent pain' and the 'continuous pain' group (categorized at Q3) during pregnancy (Q1) and during the first 6 months postpartum (Q2), where the 'continuous pain' group (Q3) seemed to report a less favourably health status.
C-reactive protein (CRP) values from blood samples drawn on the day of admission were categorized at 80 mg/L, which is applicable for predicting sepsis in patients with SIRS [ 17], and 200 mg/L, which is the suggested level for differentiating infection from other causes of shock [ 18].
There was no significant interaction between metformin and BMI categorized at either 25 or 27 (p = 0.22).> -wrap-foot> interquartiletile range a p values for treatment, * covariate interaction on ki-67 change The effect of metformin on ki-67 change in HER2-positive tumors is further illustrated in Fig. 3.
The cumulative probability of type-specific HPV detection at visits 1 through 14 was determined as a function of infection categorized at visits 1 and 14 as persistent, newly detected, cleared or absent.
